Compare Emerson Electric Co. (EMR) vs Oruka Therapeutics Inc. Common Stock (ORKA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Emerson Electric Co. vs Oruka Therapeutics Inc. Common Stock — how do they compare? Emerson Electric Co. trades at $161 (market cap $91.20B), while Oruka Therapeutics Inc. Common Stock trades at $75.2 (market cap $5.18B). The key difference: Emerson Electric Co. is far larger — about 17.6× Oruka Therapeutics Inc. Common Stock's market cap, and Emerson Electric Co. pays a 1.36% dividend while Oruka Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Emerson Electric Co. for 81 Days and Oruka Therapeutics Inc. Common Stock for 0 Days on average.
| EMR | ORKA | |
|---|---|---|
Market Cap | $91.20B | $5.18B |
Volume | 2,131,741 | 490,798 |
Sector | Industrials | Health |
52-Week High | $164.38 | $113.08 |
52-Week Low | $123.30 | $26.19 |
Typical Hold Time | 81 Days | 0 Days |
Enterprise Value | $102.28B | $4.31B |
Dividend Yield | 1.36% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Emerson Electric (EMR) trades at $161.08, down 0.85% on the day, with a bullish technical signal from moving averages. The company shows solid fundamentals with a 13.83% net income margin and consistent earnings beats in recent quarters. Revenue is projected to grow to $18.6B in 2026, and analysts maintain a consensus buy rating with a $165.90 price target, suggesting modest upside. A dividend of $0.56 per share is scheduled for payment in September 2026.
EMR presents a favorable outlook supported by earnings momentum and analyst optimism, though valuation multiples like a P/E of 35.78 are elevated. Key risks include competitive pressures and macroeconomic sensitivity. The stock's proximity to resistance at $164 may prompt near-term consolidation, but fundamental strength supports long-term growth potential.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Emerson Electric Co.
Emerson Electric is a multi-industrial conglomerate that operates under two business platforms: automation solutions and commercial and residential solutions. The latter is further subdivided into two operating segments: climate technologies, which sells HVAC and refrigeration products and services as well as tools and home products, which sells tools and compressors, among other products and services. Commercial and residential solutions boasts several household brands, including Copeland and RIDGID. Automation solutions is most known for its process manufacturing solutions, which consists of measurement instrumentation, as well as valves and actuators, among other products and services. Roughly half of the firm's geographic sales take place in the United States.
Read more on EMR →About Oruka Therapeutics Inc. Common Stock
Oruka Therapeutics, Inc. is a clinical-stage biotechnology company developing extended half-life monoclonal antibodies for plaque psoriasis, psoriatic arthritis, and related dermatologic conditions, with lead candidates ORKA-001 and ORKA-002 in clinical trials.
Read more on ORKA →
